PAPER Loreto F, Verdi S, Kia SM, Duvnjak A, Hakeem H, Fitzgerald A, Patel N, Lilja J, Win Z, Perry R, Marquand AF, Cole JH, Malhotra P
SEARCH RESULTS
18456 RESULTS
PAPER Park HH, Kim BH, Leem SH, Park YH, Chung H, Yoo DH, Park I, Nam Y, Kim S, Shin SJ, Moon M
Therapeutic Potential of Traditional Oriental Medicines in Targeting Tau Pathology: Insights from Cell-free and Cell-based Screening.
Curr Med Chem. 2024 Mar 13; PubMed.PAPER Sur S, Lin Z, Li Y, Yasar S, Rosenberg PB, Moghekar A, Hou X, Jiang D, Kalyani RR, Hazel K, Pottanat G, Xu C, Pillai JJ, Liu P, Albert M, Lu H
CO2 cerebrovascular reactivity measured with CBF-MRI in older individuals: Association with cognition, physical function, amyloid and tau proteins.
J Cereb Blood Flow Metab. 2024 Sep;44(9):1618-1628. Epub 2024 Mar 15 PubMed.Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed) (PAR-24-144)
GRANT Friday, March 15, 2024- 4:15pm National Institutes of Health Applications may request up to $100,000 direct costs/year, excluding consortium facilities and administrative (F&A) costs. The scope of the proposed project should determine the project peri
Support for Research Excellence First Independent Research (SuRE-First) Award (R16- Clinical Trial Not Allowed) (PAR-24-145)
GRANT Friday, March 15, 2024- 4:15pm National Institutes of Health Applications may request up to $125,000 direct costs/year, excluding consortium facilities and administrative (F&A) costs. The maximum period of support is 4 years. Multiple due dates; see a
AD/PD™ 2024: Advances in Science & Therapy
CONFERENCE COVERAGE SERIES Fast Plaque Clearance with Little ARIA? So Teases Trontinemab at AD/PD 2024 TauRx Parses Subgroups to Make the Case for Methylene Blue Derivative, Again Therapeutic Contenders Target Hard-to-Reach Pockets of Tau Mouse Models and Markers for Cerebral Amylo
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed) (PAR-24-121)
GRANT Friday, March 15, 2024- 4:00pm National Institute on Aging NIA intends to fund an estimate of 3-5 awards, corresponding to a total of $2.7 million, each year for fiscal years 2025, 2026, and 2027. Application budgets are not limited, but need to reflect t
NINDS Advanced Institutional Research Training Program (T32 Clinical Trial Not Allowed) (PAR-24-126)
GRANT Friday, March 15, 2024- 4:00pm National Institute of Neurological Disorders and Stroke Multiple due dates; see announcement. https://grants.nih.gov/grants/guide/pa-files/PAR-24-126.html 26 May 2026
Fast Plaque Clearance with Little ARIA? So Teases Trontinemab at AD/PD 2024
CONFERENCE COVERAGE 2024-03-15 Conference Coverage A record 4,700 people from 70 countries attended the 18th International Conference on Alzheimer’s and Parkinson’s Diseases, held March 5 to 9 in Lisbon, Portugal. Those who attended this hybrid meeting in person sometimes packed rooms
Sajjad Gerdabi
, Iran, Islamic Republic of
Dutch Neuroscience Meeting
CONFERENCE 2024-06-13 00:00:00-2024-06-14 00:00:00 Tiel, The Netherlands 13 – 14 June 2024 View Conference Website 0
Kirstin Tamucci
Columbia University
Juan Sanchez
Anne Sofie Lund
Hernando Margara
, Spain
Current Filters
- Date Range : Mar 2024 to Mar 2025 x